Cardiac Wire #57 February 13, 2023
Biosense Webster’s PFA Milestone | Forxiga’s Expanded Approval
Cardiac Wire #56 February 9, 2023
Challenging the HFpEF Treatment Dogma | Heart Disease Risk Perceptions
Cardiac Wire #55 February 6, 2023
The Power of Low Lifelong LDL-C | Abbott’s Catheter Ablation Approvals
Cardiac Wire #54 February 2, 2023
Echo AI Model for CAC Scoring | Eli Lilly Bolsters Manufacturing for GLP-1 Agonists
Cardiac Wire 53 January 30, 2023
AVS Series B | Wearable Cardiac Ultrasound
January 26, 2023
Improving Chest Pain Triage | Empagliflozin’s CKD Impact
Cardiac Wire #51 January 23, 2023
Intermittent Fasting Long Term? | Abbott’s Next-Gen Device Approval
Cardiac Wire #50 January 19, 2023
CAPLA: Simple Ablation is Best | Shockwave Acquires Neovasc
Cardiac Wire #49 January 16, 2023
Wegovy Approved for Teens | Public Interest in CPR Spikes
Cardiac Wire #48 January 12, 2023
Unraveling the Myocarditis Mystery | AstraZeneca Acquires CinCor
Cardiac Wire #47 January 9, 2023
Repatha Analysis Raises Questions | Unlocking the Potential of Genetic Testing
Cardiac Wire #46 January 4, 2023
Top 10 Heart Research Achievements of 2022 | Comparing TAVI Devices
Cardiac Wire #45 December 19, 2022
Global CVD Almanac | POTS Tied to COVID Infection & Vaccine
Cardiac Wire #44 December 15, 2022
Heart Disease Care in an Aging Population | Precision CAD Care
Cardiac Wire #43 December 12, 2022
Childhood Lp(a) Predicts Adult CVD Risk | Marital Status Impacts MI Recovery
Cardiac Wire #42 December 8, 2022
Interventional Cardiology Joins The Match | Apple V. AliveCor
Cardiac Wire #41 December 5, 2022
Is 8 Minutes of Exercise Enough? | PCR London Valves 2022 Study Drop
Cardiac Wire #40 December 1, 2022
The Heart & ADHD Meds | Rethinking HDL-C
Cardiac Wire #38 November 21, 2022
